arrow
H

Holly Holliday

children's cancer institute
H指数:15
被引数:1,270

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combined inhibition of FACT and BET disrupts transcription to suppress tumor growth in mouse models of diffuse midline glioma

联合抑制FACT和BET破坏转录以抑制弥漫性中线胶质瘤小鼠模型的肿瘤生长

2026-01-140
PRE
The development of ACT001 with Mcl-1 inhibitors as a novel combination therapy for the treatment of paediatric diffuse midline glioma

ACT001与Mcl-1抑制剂联合开发作为一种新型联合疗法,用于治疗儿童弥漫性中线胶质瘤

2025-11-010
OAAI
CHROMATIN REMODELING WITH COMBINED FACT AND BET INHIBITION DISRUPTS ONCOGENIC TRANSCRIPTION IN DIFFUSE MIDLINE GLIOMA

联合FACT和BET抑制的染色质重塑破坏弥漫性中线胶质瘤中的致癌转录

2025-11-010
OAAI
Germline analysis of an international cohort of pediatric diffuse midline glioma patients

对国际队列儿童弥漫性中线胶质瘤患者的生殖系分析

2025-03-120
PRE
High-throughput in vitro drug screening and in vivo studies identify fenretinide as a brain-penetrant DMG therapeutic

高通量体外药物筛选和体内研究将fenretinide确定为一种能够穿透血脑屏障的DMG治疗药物。

2025-02-120
PRE
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response

暂时分辨的蛋白质组学将nidogen-2鉴定为胰腺癌的共靶标,其调节纤维化和治疗反应

2024-07-052
OAAI
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset ofNUTM1-rearranged tumors

一种具有MYC样活性的MXI1-NUTM1融合蛋白在一个肿瘤亚群ofNUTM1-rearranged一种新的致癌机制

2021-01-0114
OAAI
Stromal cell diversity associated with immune evasion in human triple-negative breast cancer

人类三阴性乳腺癌中与免疫逃避相关的基质细胞多样性

2020-08-13260
OAAI
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

基底细胞样乳腺癌分化抑制因子4 (ID4) 的蛋白质组学分析

2020-06-117
OAAI